Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Carter

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|August 2, 2022
Transcriptomic diversity in human medullary thymic epithelial cellsJason A Carter, Léonie Strömich, Matthew Peacey, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
The <i>DNAJB1-PRKACA</i> Oncogenic Fusion Drives Stepwise Biliary and Pancreatic Carcinogenesis from Intraductal Precursor LesionsPatrick R Carney, Manabu Nukaya, Jason A Carter, et al.
Transfusion|February 9, 2021
Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donorsJason A Carter, Alex T Freedenberg, Jamie L Romeiser, et al.
Critical Care Medicine|April 19, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized TrialElliott Bennett-Guerrero, Jamie L Romeiser, Lillian R Talbot, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Gastroenterology|February 17, 2026
Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar CarcinomaJason A Carter, Lindsay K Dickerson, Andreas Stephanou, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|August 2, 2022
Transcriptomic diversity in human medullary thymic epithelial cellsJason A Carter, Léonie Strömich, Matthew Peacey, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
The <i>DNAJB1-PRKACA</i> Oncogenic Fusion Drives Stepwise Biliary and Pancreatic Carcinogenesis from Intraductal Precursor LesionsPatrick R Carney, Manabu Nukaya, Jason A Carter, et al.
Transfusion|February 9, 2021
Impact of serological and PCR testing requirements on the selection of COVID-19 convalescent plasma donorsJason A Carter, Alex T Freedenberg, Jamie L Romeiser, et al.
Critical Care Medicine|April 19, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York: A Double-Blind Randomized TrialElliott Bennett-Guerrero, Jamie L Romeiser, Lillian R Talbot, et al.
Gut|June 15, 2022
Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastasesKevin M Sullivan, Xiuyun Jiang, Prajna Guha, et al.
Cancer Immunology Research|November 7, 2025
Intratumoral three-cell-type clusters are a conserved feature of endogenous antitumor immunitySheela R Damle, Jason A Carter, Kristin E Goodsell, et al.
Gastroenterology|February 17, 2026
Overcoming CXCR4-Mediated T-Cell Exclusion Potentiates Antitumor Cytotoxicity in Fibrolamellar CarcinomaJason A Carter, Lindsay K Dickerson, Andreas Stephanou, et al.
Pageof 2